Kim Flint Foundation
Hope needs research.
We stand up for people with adrenocortical carcinoma – an extremely rare, aggressive cancer. We fund treatment when the standard path ends, support research and open up highly personalised medicine.
Kim's story
Kim founded this foundation. We carry it on.
At 29, Kim was diagnosed with adrenocortical carcinoma, a very rare and aggressive cancer. During her lifetime she built the Kim Flint Foundation to raise awareness for this cancer and to move research forward. Since she went to heaven, we have been continuing her work in her spirit.
In Kim's own words
At 29, I was diagnosed with adrenocortical carcinoma “out of nowhere”. I've now lived with the disease for three years. As my treatment options are slowly running out, I want to raise awareness for this rare cancer and collect donations to support research towards a better cure. Thank you for being here and for helping those of us who are ill get well again!
What we stand for
We support the German Adrenocortical Carcinoma Study Group. The aim is to make systematic therapeutic progress possible for the first time in this very rare disease – for example by making it easier to recruit for prospective patient studies – and to better assess the course of the disease, prognosis and success of different treatment approaches.
Why it matters
- 1–2
- cases per million people each year
- approx. 100
- new diagnoses per year in Germany
- ≈ 60 %
- of tumours are hormone-active
- < 15 %
- five-year survival with metastases
Our work
Three ways your donation helps
01Making treatment possible when the standard path ends
We pre-finance treatments that health insurers only reimburse once they've proven successful – so care is decided on medical grounds, not by the bill.
Learn more →
02Funding research that goes beyond today's therapies
Together with University Hospital Würzburg, we fund where a modest amount makes the difference – such as research positions for new immunotherapy approaches.
Learn more →
03Opening a new path: highly personalised medicine
In-depth genetic analysis of individual tumours and testing drugs on organoids – we're building documented case studies and exploring how AI can scale this work for many.
Learn more →Partner
Working with the leading experts
We work closely with Professor Martin Fassnacht and his team at University Hospital Würzburg – one of Europe's most important centres for the diagnosis, treatment and research of adrenocortical carcinoma.
Every gift counts.
Donate in seconds – with Apple Pay, Google Pay, card or bank transfer. Every euro goes to treatment and research.
Donate nowKim's story on Instagram
@kim_flint ↗
